Chromosome Analysis, Bone Marrow
Use for diagnosis, prognosis, and monitoring of hematopoietic neoplasms.
New York DOH Approval Status
Nondiluted bone marrow aspirate. Collect in a heparinized syringe.
Do not freeze or expose to extreme temperatures. Transfer 3 mL bone marrow to a green (sodium heparin). (Min: 0.5 mL)
Frozen specimens. Clotted specimens.
Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable
Refer to report
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Laboratory Developed Test (LDT)
These studies involve culturing of living cells; therefore, turnaround times given represent average times, which are subject to multiple variables.
A processing fee will be charged if this procedure is canceled at the client's request after the test has been set up or if the specimen integrity is inadequate to allow culture growth.
Although bone marrow is the recommended specimen type for hematological disorder studies, blood can be substituted if bone marrow cannot be obtained. Refer to Chromosome Analysis, Leukemic Blood (ARUP test code 2002290). This test must be ordered using Oncology test request form #43099 or through your ARUP interface.
Specimens enrolled in external studies (e.g. COG studies) requiring additional work-up and/or supplementary data collection and submission will have the following charges added based on type and extent of work performed: Cytogenetics Study Submission - Basic (3006071) or Cytogenetics Study Submission - Extensive (3006072).
88237; 88264; for COG studies, add 88299
|Component Test Code*||Component Chart Name||LOINC|
|0097605||Chromosome Analysis, Bone Marrow||50659-2|
|2002200||EER Chromosome Analysis Bone Marrow||50659-2|
- Bone marrow karyotype
- Hematologic Chromosome Analysis